Sudden Cardiac Death and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy

Area of Science:

• Cardiology
• Genetics
• Medical Devices

Background:

• Hypertrophic cardiomyopathy (HCM) is the most prevalent inherited cardiac disease.
• HCM significantly elevates the risk of ventricular arrhythmias and sudden cardiac death, particularly in young, asymptomatic individuals like athletes.
• Implantable cardiac defibrillators (ICDs) are effective for managing arrhythmias but carry risks of morbidity, including inappropriate shocks and device complications.

Purpose of the Study:

• To emphasize the critical need for accurate prognostication in guiding ICD implantation for HCM patients.
• To highlight the complexity in decision-making due to traditional risk factors, modifiers, and predictive models.
• To underscore the evolving landscape of risk stratification with advanced imaging techniques.

Main Methods:

• Review of traditional risk factors and emerging risk modifiers in HCM.
• Integration of advanced imaging, specifically late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (cMRI).
• Consideration of patient-specific factors, including age and disease substrate, in device selection and programming.

Main Results:

• Accurate prognostication is essential for optimizing ICD implantation in HCM.
• Advanced imaging like cMRI with LGE improves risk stratification.
• Device selection and programming in HCM require tailored approaches considering disease characteristics and patient age.

Conclusions:

• Effective risk stratification is paramount for judicious ICD implantation in hypertrophic cardiomyopathy.
• The use of advanced imaging modalities like cMRI is enhancing prognostication capabilities.
• Personalized device management, considering disease substrate and patient demographics, is crucial for hypertrophic cardiomyopathy patients.